# Epidemiology of chronic kidney diseases in the Republic of Guinea; future dialysis needs

**Authors:** Alpha Oumar Bah, Cisse Lamine, Mamadou Cellou Balde, Mamadou Lamine Yaya Bah, Lionel Rostaing

PMC · DOI: 10.12860/jnp.2015.24 · Journal of Nephropathology · 2015-10-01

## TL;DR

This study examines the growing problem of chronic kidney disease in Guinea and highlights the urgent need for more dialysis resources.

## Contribution

The study provides the first detailed assessment of CKD and ESRD in Guinea, estimating future dialysis needs.

## Key findings

- 70.5% of patients already had end-stage renal disease upon admission.
- Only 36.3% of ESRD patients had access to haemodialysis.
- Mortality was significantly linked to terminal CKD, vascular nephropathy, and unknown nephropathies.

## Abstract

Background: Chronic kidney disease (CKD) is increasing worldwide and can lead to end-stage renal disease (ESRD).

Objectives: Because few patients with ESRD in the Republic of Guinea have access to haemodialysis, we retrospectively evaluated the prevalence of CKD, ESRD and access to supportive therapies.

Patients and Methods: 579 CKD patients (304 males; mean age: 44 ± 16 years) were admitted into Conakry nephrology department, the only centre in the Republic of Guinea, between 2009 and 2013. Most patients (63%) resided within Conakry (the capital), 12.5% came from lower Guinea, 11.7% from middle Guinea, 7.9% from upper Guinea and 4.8% from forest Guinea.

Results: Reasons for referral were increased serum creatinine (49.5%), hypertension (27%) and diffuse edema (17%). Also, 11% were diabetic, 12.5% were smokers, 17% were HIV-positive, 8.3% were HBV-positive and 15% were HCV-positive. The most frequent symptom at admission was nausea/vomiting (56%). Upon admission, 70.5% of patients already had ESRD. Although no kidney biopsies were performed it was assumed that 34% and 27% of patients had vascular nephropathy and chronic glomerulonephritis, respectively. Of the 385 ESRD patients, only 140 (36.3%) had access to haemodialysis (two sessions/week, 4 hours each). Most patients that received haemodialysis resided within the Conakry region (P < 0.0001). There were significant associations between mortality and (i) terminal stage of CKD (P = 0.0005), (ii) vascular nephropathy (P = 0.002), and (iii) nephropathies of unknown origin (P = 0.0001).

Conclusions: A fourfold increase in haemodialysis machines is needed in Conakry, plus four new nephrology/haemodialysis centres within the Republic of Guinea, each holding ≥30 haemodialysis machines.

## Linked entities

- **Diseases:** chronic kidney disease (MONDO:0005300), end-stage renal disease (MONDO:0004375), diabetes (MONDO:0005015)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** dizziness (MESH:D004244), urinary infection (MESH:D014552), nausea (MESH:D009325), chronic glomerulonephritis (MESH:D005921), anorexia (MESH:D000855), infection (MESH:D007239), infectious diseases (MESH:D003141), cryoglobulinemia (MESH:D003449), malnutrition (MESH:D044342), uremic symptoms (MESH:D006463), proteinuria (MESH:D011507), headache (MESH:D006261), renal failure (MESH:D051437), CKD (MESH:D051436), Vascular nephropathies (MESH:D014652), asthenia (MESH:D001247), HBV infection (MESH:D006509), nausea/vomiting (MESH:D020250), membranoproliferative glomerulonephritis (MESH:D015432), dyspnea (MESH:D004417), HIV (MESH:D015658), tinnitus (MESH:D014012), gastrointestinal symptoms (MESH:D012817), diabetes (MESH:D003920), membranous nephropathy (MESH:D015433), ESRD (MESH:D007676), acute kidney failure (MESH:D058186), hypertension (MESH:D006973), deaths (MESH:D003643), diabetes-related nephropathies (MESH:D003928), uropathy (MESH:C536483), edema (MESH:D004487), viral infections (MESH:D014777), impairment to renal function (MESH:D007674), vomiting (MESH:D014839)
- **Chemicals:** creatinine (MESH:D003404)
- **Species:** Ebola virus [taxon 186536], Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4596297/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4596297/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC4596297/full.md

---
Source: https://tomesphere.com/paper/PMC4596297